(Q39492284)

English

Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group

scientific article

Statements

Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group (English)
Feldman M
Harford WV
Fisher RS
Sampliner RE
Murray SB
Greski-Rose PA
Jennings DE
1 August 1993
1212-1217

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit